Marshall Wace

Founded in London in 1997, Marshall Wace is an employee-owned investment management firm specializing in global long/short equity strategies. The company employs both fundamental and quantitative analysis to invest in public equity markets worldwide.

Steven Binetter

Portfolio Manager

Andrew Goldberg

Managing Director

Amit Rajpal

Managing Partner and Portfolio Manager

Past deals in South Dakota

SAb Biotherapeutics

Post in 2023
SAB Biotherapeutics is a clinical-stage biopharmaceutical company established in 2014, headquartered in Sioux Falls, South Dakota with additional offices in Cambridge, Massachusetts. The company specializes in developing immunotherapies using its proprietary DiversitAb platform, which employs transchromosomic cattle to produce large quantities of targeted human polyclonal antibodies without relying on human plasma or serum. SAB's pipeline includes therapies for conditions such as Type 1 diabetes (SAB-142), seasonal influenza (SAB-176), and Middle East Respiratory Syndrome Coronavirus (MERS-CoV, SAB-301).
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.